Philips and Paige team up to bring Artificial Intelligence (AI) to clinical pathology diagnostics
December 05 2019 - 4:00AM
Philips and Paige team up to bring Artificial Intelligence (AI) to
clinical pathology diagnostics
December 5, 2019
AI-based cancer assessment tools are poised to help
pathologists improve speed and accuracy of cancer diagnostics,
ultimately leading to better patient care
Amsterdam, The Netherlands – Royal Philips (
(NYSE: PHG, AEX: PHIA), a global leader in health technology, and
Paige, a leader in computational pathology, announced today a
strategic collaboration to deliver clinical-grade AI applications
to pathology laboratories. These AI technologies, starting with
Paige Prostate, aim to help pathologists identify, quantify and
characterize cancer in tissue samples and make precise diagnoses
more efficiently. This may, ultimately, positively impact
pathologist’s workflow and treatment planning for patients.
Pathologists play a crucial role in the detection and diagnosis
of a broad range of diseases, including cancer. The increasing
number of cancer cases in the aging population, and rapid advances
in personalized medicine have resulted in significant increases in
the complexity of pathology diagnostics and the workload imposed on
pathologists. Digital images of tissue samples make it possible for
pathologists to easily diagnose these samples on a computer display
using advanced imaging analysis and workflow software.
Paige’s technology has demonstrated promising results, and the
collaboration aims to deliver this kind of technology into routine
clinical practice. Several pathology laboratories have already
converted their glass slide-based workflow to digital, using the
clinically approved digital pathology solution from Philips. Once
digital images are available, the CE marked Paige Prostate software
is applied automatically to detect and localize prostate cancer.
This technology provides pathologists with valuable information
they can use in their evaluation of prostate biopsies.
“We want to empower pathologists with the latest computational
pathology solutions to enhance the diagnosis and treatment of
cancer,” said Marlon Thompson, Business Leader of Digital &
Computational Pathology at Philips. “Through our open digital
pathology platform approach, we team up with leading computational
pathology solution providers, such as Paige, to create the ultimate
end-to-end oncology workflow for our customers.”
“Pathology is transforming into a digital discipline and holds a
strong promise for using AI solutions to aid, streamline, and
enhance decision-making,” said Leo Grady, CEO of Paige. “Together
with digital pathology providers, starting with Philips, one of the
leaders in the clinical digital pathology space, we want to convert
this promise into a clinical reality that supports pathologists and
their patients.”
Philips IntelliSite Pathology Solution in combination with Paige
Prostate aims to provide an intuitive digital & computational
pathology workflow experience. Philips plans to offer the CE-marked
Paige Prostate to European pathology labs in 2020. AI solutions for
other markets and additional disease areas are expected to follow
suit. Visit www.philips.com/digitalpathology and
https://paige.ai. for more information.
For further information, please contact:
Joost MalthaPhilips Global Press OfficeTel. : +31 6 10 55
8116Email: joost.maltha@philips.com
Nicole RodriguesNRPR Group – For PaigeTel.: +1 650 815
5069Email: nicole@nrprgroup.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment, and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring, and health informatics, as well as in consumer health
and home care. Philips generated 2018 sales of EUR 18.1 billion and
employs approximately 80,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
About Paige.AIPaige.AI is the leading start-up
focused on building the best artificial intelligence in clinical
medicine to transform how doctors diagnose and treat cancer. Based
in New York, Paige.AI is bringing together the world’s leading
experts in AI, computational pathology and clinical practice to
improve patient care through a quantum leap forward in efficacy and
efficiency. For more information, please visit:
https://paige.ai.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024